Stay updated with breaking news from Benjamin Zeskind. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Given the large stake in the stock by institutions, Immuneering's stock price might be vulnerable to their...
Key Insights Immuneering's significant insider ownership suggests inherent interests in company's expansion A total of...
Operator: Welcome to the Immuneering Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.